Annual SG&A
$18.42 M
-$7.68 M-29.43%
31 December 2023
Summary:
Mereo BioPharma annual selling, general & administrative expenses is currently $18.42 million, with the most recent change of -$7.68 million (-29.43%) on 31 December 2023. During the last 3 years, it has fallen by -$10.50 million (-36.30%). MREO annual SG&A is now -36.30% below its all-time high of $28.92 million, reached on 31 December 2020.MREO Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$6.20 M
-$1.67 M-21.16%
30 September 2024
Summary:
Mereo BioPharma quarterly selling, general & administrative expenses is currently $6.20 million, with the most recent change of -$1.67 million (-21.16%) on 30 September 2024. Over the past year, it has increased by +$495.00 thousand (+8.67%). MREO quarterly SG&A is now -21.16% below its all-time high of $7.87 million, reached on 30 June 2024.MREO Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.74 B
-$455.84 M-35.36%
30 September 2024
Summary:
Mereo BioPharma TTM selling, general & administrative expenses is currently -$1.74 billion, with the most recent change of -$455.84 million (-35.36%) on 30 September 2024. Over the past year, it has dropped by -$1.76 billion (-11868.29%). MREO TTM SG&A is now -9562.66% below its all-time high of $23.57 million, reached on 30 September 2024.MREO TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MREO Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.4% | +8.7% | -10000.0% |
| 3 y3 years | -36.3% | - | - |
| 5 y5 years | +23.3% | - | - |
MREO Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -36.3% | at low | -21.2% | +132.4% | -122.5% | at low |
| 5 y | 5 years | -36.3% | +23.3% | -21.2% | +132.4% | -476.8% | at low |
| alltime | all time | -36.3% | +28.5% | -21.2% | +132.4% | -9562.7% | at low |
Mereo BioPharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.20 M(-21.2%) | $23.57 M(+2.1%) |
| June 2024 | - | $7.87 M(+33.2%) | $23.08 M(+29.1%) |
| Mar 2024 | - | $5.91 M(+64.2%) | $17.88 M(-3.0%) |
| Dec 2023 | $18.42 M(-29.4%) | $3.60 M(-37.0%) | $18.42 M(+24.3%) |
| Sept 2023 | - | $5.71 M(+113.9%) | $14.83 M(+62.6%) |
| June 2023 | - | $2.67 M(-58.6%) | $9.12 M(+41.4%) |
| Mar 2023 | - | $6.45 M | $6.45 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $26.11 M(+21.4%) | - | - |
| Dec 2021 | $21.50 M(-25.6%) | - | - |
| Dec 2020 | $28.92 M(+38.7%) | - | - |
| Dec 2019 | $20.86 M(+39.6%) | - | - |
| Dec 2018 | $14.94 M(+3.4%) | - | - |
| Dec 2017 | $14.46 M(+0.9%) | - | - |
| Dec 2016 | $14.33 M | - | - |
FAQ
- What is Mereo BioPharma annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Mereo BioPharma?
- What is Mereo BioPharma annual SG&A year-on-year change?
- What is Mereo BioPharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Mereo BioPharma?
- What is Mereo BioPharma quarterly SG&A year-on-year change?
- What is Mereo BioPharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Mereo BioPharma?
- What is Mereo BioPharma TTM SG&A year-on-year change?
What is Mereo BioPharma annual selling, general & administrative expenses?
The current annual SG&A of MREO is $18.42 M
What is the all time high annual SG&A for Mereo BioPharma?
Mereo BioPharma all-time high annual selling, general & administrative expenses is $28.92 M
What is Mereo BioPharma annual SG&A year-on-year change?
Over the past year, MREO annual selling, general & administrative expenses has changed by -$7.68 M (-29.43%)
What is Mereo BioPharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of MREO is $6.20 M
What is the all time high quarterly SG&A for Mereo BioPharma?
Mereo BioPharma all-time high quarterly selling, general & administrative expenses is $7.87 M
What is Mereo BioPharma quarterly SG&A year-on-year change?
Over the past year, MREO quarterly selling, general & administrative expenses has changed by +$495.00 K (+8.67%)
What is Mereo BioPharma TTM selling, general & administrative expenses?
The current TTM SG&A of MREO is -$1.74 B
What is the all time high TTM SG&A for Mereo BioPharma?
Mereo BioPharma all-time high TTM selling, general & administrative expenses is $23.57 M
What is Mereo BioPharma TTM SG&A year-on-year change?
Over the past year, MREO TTM selling, general & administrative expenses has changed by -$1.76 B (-11868.29%)